Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales (2016 - 2025)

Historic Return on Sales for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to 0.33%.

  • Ironwood Pharmaceuticals' Return on Sales rose 2900.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 9900.0%. This contributed to the annual value of 0.29% for FY2024, which is 31300.0% up from last year.
  • Ironwood Pharmaceuticals' Return on Sales amounted to 0.33% in Q3 2025, which was up 2900.0% from 0.28% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Return on Sales high stood at 3.76% for Q2 2021, and its period low was 10.15% during Q2 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.35% (2021), whereas its average is 0.21%.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Sales crashed by -105300bps in 2023, and later soared by 101400bps in 2024.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Return on Sales stood at 0.35% in 2021, then increased by 29bps to 0.46% in 2022, then crashed by -526bps to 1.94% in 2023, then skyrocketed by 159bps to 1.15% in 2024, then crashed by -71bps to 0.33% in 2025.
  • Its Return on Sales was 0.33% in Q3 2025, compared to 0.28% in Q2 2025 and 0.91% in Q1 2025.